Literature DB >> 28633697

Capacity strengthening through pre-migration tuberculosis screening programmes: IRHWG experiences.

P Douglas1, D L Posey2, D Zenner3, J Robson4, I Abubakar5, G Giovinazzo6.   

Abstract

Effective tuberculosis (TB) prevention and care for migrants requires population health-based approaches that treat the relationship between migration and health as a progressive, interactive process influenced by many variables and addressed as far upstream in the process as possible. By including capacity building in source countries, pre-migration medical screening has the potential to become an integral component of public health promotion, as well as infection and disease prevention, in migrant-receiving nations, while simultaneously increasing capabilities in countries of origin. This article describes the collaborative experiences of five countries (Australia, Canada, New Zealand, United Kingdom and the United States of America, members of the Immigration and Refugee Health Working Group [IRHWG]), with similar pre-migration screening programmes for TB that are mandated. Qualitative examples of capacity building through IRHWG programmes are provided. Combined, the IRHWG member countries screen approximately 2 million persons overseas every year. Large-scale pre-entry screening programmes undertaken by IRHWG countries require building additional capacity for health care providers, radiology facilities and laboratories. This has resulted in significant improvements in laboratory and treatment capacity, providing availability of these facilities for national public health programmes. As long as global health disparities and disease prevalence differentials exist, national public health programmes and policies in migrant-receiving nations will continue to be challenged to manage the diseases prevalent in these migrating populations. National TB programmes and regulatory systems alone will not be able to achieve TB elimination. The management of health issues resulting from population mobility will require integration of national and global health initiatives which, as demonstrated here, can be supported through the capacity-building endeavours of pre-migration screening programmes.

Entities:  

Mesh:

Year:  2017        PMID: 28633697     DOI: 10.5588/ijtld.17.0019

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Setting the stage: reviewing current knowledge on the health of New Zealand immigrants-an integrative review.

Authors:  Blessing Kanengoni; Sari Andajani-Sutjahjo; Eleanor Holroyd
Journal:  PeerJ       Date:  2018-08-23       Impact factor: 2.984

2.  Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries.

Authors:  Jonathon R Campbell; James C Johnston; Victoria J Cook; Mohsen Sadatsafavi; R Kevin Elwood; Fawziah Marra
Journal:  Emerg Infect Dis       Date:  2019-04       Impact factor: 6.883

Review 3.  Immigrant and Refugee Health: A Centers for Disease Control and Prevention Perspective on Protecting the Health and Health Security of Individuals and Communities During Planned Migrations.

Authors:  Tarissa Mitchell; Michelle Weinberg; Drew L Posey; Martin Cetron
Journal:  Pediatr Clin North Am       Date:  2019-06       Impact factor: 3.278

4.  Detecting Mycobacterium tuberculosis Infection in Children Migrating to Australia.

Authors:  Ingrid Laemmle-Ruff; Stephen M Graham; Bridget Williams; Danielle Horyniak; Suman S Majumdar; Georgia A Paxton; Lila V Soares Caplice; Margaret E Hellard; James M Trauer
Journal:  Emerg Infect Dis       Date:  2022-09       Impact factor: 16.126

5.  Enhanced surveillance for tuberculosis among foreign-born persons, Finland, 2014-2016.

Authors:  Pirre E Räisänen; Hanna Soini; Pirjo Turtiainen; Tuula Vasankari; Petri Ruutu; J Pekka Nuorti; Outi Lyytikäinen
Journal:  BMC Public Health       Date:  2018-05-09       Impact factor: 3.295

6.  Tuberculosis in migrants to Australia: Outcomes of a national screening program.

Authors:  James M Trauer; Bridget Williams; Ingrid Laemmle-Ruff; Danielle Horyniak; Lila V Soares Caplice; Emma S McBryde; Suman S Majumdar; Stephen M Graham; Margaret E Hellard
Journal:  Lancet Reg Health West Pac       Date:  2021-03-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.